{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T06:05:25Z","timestamp":1793858725836,"version":"4.6.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T00:00:00Z","timestamp":1775865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"vor","delay-in-days":52,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203764"],"award-info":[{"award-number":["82203764"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-48506-2","type":"journal-article","created":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T05:24:07Z","timestamp":1775885047000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Potential role of leptin in colorectal cancer liver metastasis involving lipid metabolic reprogramming and immunosuppressive macrophage polarization"],"prefix":"10.1038","volume":"16","author":[{"given":"Yuchen","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueran","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yidong","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueying","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shipeng","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,11]]},"reference":[{"issue":"3","key":"48506_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 71 (3), 209\u2013249 (2021).","journal-title":"CA Cancer J. Clin."},{"issue":"9927","key":"48506_CR2","first-page":"1490","volume":"383","author":"H Brenner","year":"2014","unstructured":"Brenner, H., Kloor, M. & Pox, C. P. Colorectal cancer Lancet, 383(9927): 1490\u20131502. (2014).","journal-title":"Colorectal cancer Lancet"},{"issue":"3","key":"48506_CR3","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/S2468-1253(21)00426-X","volume":"7","author":"SG Patel","year":"2022","unstructured":"Patel, S. G. et al. The rising tide of early-onset colorectal cancer: a comprehensive review of epidemiology, clinical features, biology, risk factors, prevention, and early detection. Lancet Gastroenterol. Hepatol. 7 (3), 262\u2013274 (2022).","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"3","key":"48506_CR4","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1053\/j.gastro.2021.10.035","volume":"162","author":"SC Shah","year":"2022","unstructured":"Shah, S. C. & Itzkowitz, S. H. Colorectal Cancer in Inflammatory Bowel Disease: Mechanisms and Management. Gastroenterology 162 (3), 715\u2013730e3 (2022).","journal-title":"Gastroenterology"},{"issue":"7","key":"48506_CR5","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1001\/jama.2021.0106","volume":"325","author":"LH Biller","year":"2021","unstructured":"Biller, L. H. & Schrag, D. Diagnosis and Treatment of Metastatic Colorectal Cancer: A Review. JAMA 325 (7), 669\u2013685 (2021).","journal-title":"JAMA"},{"issue":"4","key":"48506_CR6","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.tips.2023.01.003","volume":"44","author":"AE Shin","year":"2023","unstructured":"Shin, A. E., Giancotti, F. G. & Rustgi, A. K. Metastatic colorectal cancer: mechanisms and emerging therapeutics. Trends Pharmacol. Sci. 44 (4), 222\u2013236 (2023).","journal-title":"Trends Pharmacol. Sci."},{"issue":"1","key":"48506_CR7","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1186\/s12967-024-05901-5","volume":"22","author":"S Dai","year":"2024","unstructured":"Dai, S. et al. miR-122\/NEGR1 axis contributes colorectal cancer liver metastasis by PI3K\/AKT pathway and macrophage modulation. J. Transl Med. 22 (1), 1060 (2024).","journal-title":"J. Transl Med."},{"issue":"1","key":"48506_CR8","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41392-022-00922-2","volume":"7","author":"H Zhou","year":"2022","unstructured":"Zhou, H. et al. Colorectal liver metastasis: molecular mechanism and interventional therapy. Signal. Transduct. Target. Ther. 7 (1), 70 (2022).","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"6","key":"48506_CR9","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.jacc.2020.11.069","volume":"77","author":"N Perakakis","year":"2021","unstructured":"Perakakis, N., Farr, O. M. & Mantzoros, C. S. Leptin in Leanness and Obesity: JACC State-of-the-Art Review. J. Am. Coll. Cardiol. 77 (6), 745\u2013760 (2021).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"48506_CR10","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/sj.bjc.6606013","volume":"104","author":"W Zhou","year":"2011","unstructured":"Zhou, W., Guo, S. & Gonzalez-Perez, R. R. Leptin pro-angiogenic signature in breast cancer is linked to IL-1 signalling. Br. J. Cancer. 104 (1), 128\u2013137 (2011).","journal-title":"Br. J. Cancer"},{"issue":"2","key":"48506_CR11","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1677\/ERC-06-0027","volume":"14","author":"C Chen","year":"2007","unstructured":"Chen, C. et al. Leptin induces proliferation and anti-apoptosis in human hepatocarcinoma cells by up-regulating cyclin D1 and down-regulating Bax via a Janus kinase 2-linked pathway. Endocr. Relat. Cancer. 14 (2), 513\u2013529 (2007).","journal-title":"Endocr. Relat. Cancer"},{"issue":"4","key":"48506_CR12","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.jhep.2021.11.009","volume":"76","author":"E Scorletti","year":"2022","unstructured":"Scorletti, E. & Carr, R. M. A new perspective on NAFLD: Focusing on lipid droplets. J. Hepatol. 76 (4), 934\u2013945 (2022).","journal-title":"J. Hepatol."},{"issue":"2","key":"48506_CR13","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1002\/cac2.12257","volume":"42","author":"P Schwartsburd","year":"2022","unstructured":"Schwartsburd, P. Lipid droplets: could they be involved in cancer growth and cancer-microenvironment communications? Cancer Commun. (Lond). 42 (2), 83\u201387 (2022).","journal-title":"Cancer Commun. (Lond)"},{"key":"48506_CR14","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1146\/annurev.physiol.62.1.413","volume":"62","author":"RS Ahima","year":"2000","unstructured":"Ahima, R. S. & Flier, J. S. Leptin Annu. Rev. Physiol., 62: 413\u2013437. (2000).","journal-title":"Leptin Annu. Rev. Physiol."},{"issue":"3","key":"48506_CR15","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.bbadis.2013.05.009","volume":"1842","author":"RB Harris","year":"2014","unstructured":"Harris, R. B. Direct and indirect effects of leptin on adipocyte metabolism. Biochim. Biophys. Acta. 1842 (3), 414\u2013423 (2014).","journal-title":"Biochim. Biophys. Acta"},{"issue":"6","key":"48506_CR16","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/nrendo.2016.222","volume":"13","author":"H Cui","year":"2017","unstructured":"Cui, H., Lopez, M. & Rahmouni, K. The cellular and molecular bases of leptin and ghrelin resistance in obesity. Nat. Rev. Endocrinol. 13 (6), 338\u2013351 (2017).","journal-title":"Nat. Rev. Endocrinol."},{"issue":"5","key":"48506_CR17","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/nrendo.2011.184","volume":"8","author":"S Ando","year":"2011","unstructured":"Ando, S. & Catalano, S. The multifactorial role of leptin in driving the breast cancer microenvironment. Nat. Rev. Endocrinol. 8 (5), 263\u2013275 (2011).","journal-title":"Nat. Rev. Endocrinol."},{"key":"48506_CR18","doi-asserted-by":"crossref","unstructured":"Han, D. S. & Lee, E. O. Leptin Promotes Vasculogenic Mimicry in Breast Cancer Cells by Regulating Aquaporin-1. Int. J. Mol. Sci., 25(10). (2024).","DOI":"10.3390\/ijms25105215"},{"key":"48506_CR19","doi-asserted-by":"crossref","unstructured":"de Candia, P. et al. The pleiotropic roles of leptin in metabolism, immunity, and cancer. J. Exp. Med., 218(5). (2021).","DOI":"10.1084\/jem.20191593"},{"issue":"8","key":"48506_CR20","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.tem.2020.05.004","volume":"31","author":"R Vigneri","year":"2020","unstructured":"Vigneri, R., Sciacca, L. & Vigneri, P. Rethinking the Relationship between Insulin and Cancer. Trends Endocrinol. Metab. 31 (8), 551\u2013560 (2020).","journal-title":"Trends Endocrinol. Metab."},{"issue":"40","key":"48506_CR21","doi-asserted-by":"publisher","first-page":"65441","DOI":"10.18632\/oncotarget.11761","volume":"7","author":"H Cao","year":"2016","unstructured":"Cao, H. et al. Leptin promotes migration and invasion of breast cancer cells by stimulating IL-8 production in M2 macrophages. Oncotarget 7 (40), 65441\u201365453 (2016).","journal-title":"Oncotarget"},{"issue":"1","key":"48506_CR22","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.metabol.2014.10.012","volume":"64","author":"SA Polyzos","year":"2015","unstructured":"Polyzos, S. A., Kountouras, J. & Mantzoros, C. S. Leptin in nonalcoholic fatty liver disease: a narrative review. Metabolism 64 (1), 60\u201378 (2015).","journal-title":"Metabolism"},{"key":"48506_CR23","doi-asserted-by":"crossref","unstructured":"Bian, X. et al. Lipid metabolism and cancer. J. Exp. Med., 218(1). (2021).","DOI":"10.1084\/jem.20201606"},{"issue":"1","key":"48506_CR24","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s40880-018-0301-4","volume":"38","author":"C Cheng","year":"2018","unstructured":"Cheng, C. et al. Lipid metabolism reprogramming and its potential targets in cancer. Cancer Commun. (Lond). 38 (1), 27 (2018).","journal-title":"Cancer Commun. (Lond)"},{"issue":"10","key":"48506_CR25","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/j.devcel.2021.04.013","volume":"56","author":"LA Broadfield","year":"2021","unstructured":"Broadfield, L. A. et al. Lipid metabolism in cancer: New perspectives and emerging mechanisms. Dev. Cell. 56 (10), 1363\u20131393 (2021).","journal-title":"Dev. Cell."},{"issue":"12","key":"48506_CR26","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1002\/cac2.12360","volume":"42","author":"X Yin","year":"2022","unstructured":"Yin, X. et al. Lipid metabolism in pancreatic cancer: emerging roles and potential targets. Cancer Commun. (Lond). 42 (12), 1234\u20131256 (2022).","journal-title":"Cancer Commun. (Lond)"},{"issue":"7","key":"48506_CR27","doi-asserted-by":"publisher","first-page":"111668","DOI":"10.1016\/j.celrep.2022.111668","volume":"41","author":"Y Hou","year":"2022","unstructured":"Hou, Y. et al. FABP5 controls macrophage alternative activation and allergic asthma by selectively programming long-chain unsaturated fatty acid metabolism. Cell. Rep. 41 (7), 111668 (2022).","journal-title":"Cell. Rep."},{"issue":"7","key":"48506_CR28","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/s41419-024-06919-9","volume":"15","author":"G Lin","year":"2024","unstructured":"Lin, G. et al. PPAR-gamma\/NF-kB\/AQP3 axis in M2 macrophage orchestrates lung adenocarcinoma progression by upregulating IL-6. Cell. Death Dis. 15 (7), 532 (2024).","journal-title":"Cell. Death Dis."},{"issue":"8","key":"48506_CR29","doi-asserted-by":"publisher","first-page":"3201","DOI":"10.7150\/ijbs.96831","volume":"20","author":"F Lu","year":"2024","unstructured":"Lu, F. et al. Hypoxic tumor-derived exosomal miR-4488 induces macrophage M2 polarization to promote liver metastasis of pancreatic neuroendocrine neoplasm through RTN3\/FABP5 mediated fatty acid oxidation. Int. J. Biol. Sci. 20 (8), 3201\u20133218 (2024).","journal-title":"Int. J. Biol. Sci."},{"issue":"3","key":"48506_CR30","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.3390\/cancers6031670","volume":"6","author":"T Chanmee","year":"2014","unstructured":"Chanmee, T. et al. Tumor-associated macrophages as major players in the tumor microenvironment. Cancers (Basel). 6 (3), 1670\u20131690 (2014).","journal-title":"Cancers (Basel)"},{"key":"48506_CR31","doi-asserted-by":"crossref","unstructured":"Wang, H., Tian, T. & Zhang, J. Tumor-Associated Macrophages (TAMs) in Colorectal Cancer (CRC): From Mechanism to Therapy and Prognosis. Int J Mol Sci, 22(16). (2021).","DOI":"10.3390\/ijms22168470"},{"key":"48506_CR32","doi-asserted-by":"crossref","unstructured":"Kim, J. & Bae, J. S. Tumor-Associated Macrophages and Neutrophils in Tumor Microenvironment. Mediators Inflamm, 2016: p. 6058147. (2016).","DOI":"10.1155\/2016\/6058147"},{"key":"48506_CR33","doi-asserted-by":"publisher","first-page":"583084","DOI":"10.3389\/fimmu.2020.583084","volume":"11","author":"Y Pan","year":"2020","unstructured":"Pan, Y. et al. Tumor-Associated Macrophages in Tumor Immunity. Front. Immunol. 11, 583084 (2020).","journal-title":"Front. Immunol."},{"issue":"1","key":"48506_CR34","first-page":"39","volume":"141","author":"BZ Qian","year":"2010","unstructured":"Qian, B. Z. & Pollard, J. W. Macrophage Divers. enhances tumor progression metastasis Cell., 141(1): 39\u201351. (2010).","journal-title":"Macrophage Divers. enhances tumor progression metastasis Cell."},{"issue":"6","key":"48506_CR35","doi-asserted-by":"publisher","first-page":"R246","DOI":"10.1016\/j.cub.2020.01.031","volume":"30","author":"L Cassetta","year":"2020","unstructured":"Cassetta, L. & Pollard, J. W. Tumor-associated macrophages. Curr. Biol. 30 (6), R246\u2013R248 (2020).","journal-title":"Curr. Biol."},{"key":"48506_CR36","doi-asserted-by":"publisher","first-page":"105111","DOI":"10.1016\/j.phrs.2020.105111","volume":"161","author":"SY Zhang","year":"2020","unstructured":"Zhang, S. Y. et al. Tumor-associated macrophages: A promising target for a cancer immunotherapeutic strategy. Pharmacol. Res. 161, 105111 (2020).","journal-title":"Pharmacol. Res."},{"issue":"1","key":"48506_CR37","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1186\/s12935-024-03422-1","volume":"24","author":"S Dai","year":"2024","unstructured":"Dai, S. et al. miR-455\/GREM1 axis promotes colorectal cancer progression and liver metastasis by affecting PI3K\/AKT pathway and inducing M2 macrophage polarization. Cancer Cell. Int. 24 (1), 235 (2024).","journal-title":"Cancer Cell. Int."},{"issue":"4","key":"48506_CR38","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.jhep.2023.12.015","volume":"80","author":"AM Shiri","year":"2024","unstructured":"Shiri, A. M. et al. IL-10 dampens antitumor immunity and promotes liver metastasis via PD-L1 induction. J. Hepatol. 80 (4), 634\u2013644 (2024).","journal-title":"J. Hepatol."},{"issue":"2","key":"48506_CR39","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1136\/gutjnl-2021-325808","volume":"72","author":"KM Sullivan","year":"2023","unstructured":"Sullivan, K. M. et al. Blockade of interleukin 10 potentiates antitumour immune function in human colorectal cancer liver metastases. Gut 72 (2), 325\u2013337 (2023).","journal-title":"Gut"},{"key":"48506_CR40","doi-asserted-by":"crossref","unstructured":"Sun, Z. et al. Exosomal circPOLQ promotes macrophage M2 polarization via activating IL-10\/STAT3 axis in a colorectal cancer model. J. Immunother Cancer, 12(5). (2024).","DOI":"10.1136\/jitc-2023-008491"},{"issue":"9","key":"48506_CR41","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.trecan.2023.05.003","volume":"9","author":"MA Salkeni","year":"2023","unstructured":"Salkeni, M. A. & Naing, A. Interleukin-10 in cancer immunotherapy: from bench to bedside. Trends Cancer. 9 (9), 716\u2013725 (2023).","journal-title":"Trends Cancer"},{"issue":"1","key":"48506_CR42","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28 (1), 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"48506_CR43","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 28 (11), 1947\u20131951 (2019).","journal-title":"Protein Sci."},{"issue":"D1","key":"48506_CR44","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M. et al. KEGG: biological systems database as a model of the real world. Nucleic Acids Res. 53 (D1), D672\u2013D677 (2025).","journal-title":"Nucleic Acids Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48506-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48506-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48506-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T08:53:15Z","timestamp":1780390395000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48506-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,11]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["48506"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-48506-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,11]]},"assertion":[{"value":"19 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All in vivo animal experiments were approved by the Committee on the Ethics of Animal Experiments of Nanjing Medical University. We hereby confirm that the present study has been reported in accordance with the ARRIVE (Animal Research: Reporting of In Vivo Experiments) guidelines. All aspects of the animal experiments, including the experimental design, animal selection and care, details of interventions, data collection and analysis, have been reported comprehensively and transparently in accordance with the requirements of the ARRIVE guidelines. We have strived to ensure the integrity and rigor of our reporting to promote the reproducibility and reliability of the research findings.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board statement"}},{"value":"Written informed consent was obtained from all subjects involved in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent st<!--Emphasis Type='Bold' removed-->atement"}}],"article-number":"16911"}}